NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.

Authors:
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM and 14 more

Journal:
Acta Pharmacol Sin

Publication Year: 2021

DOI:
10.1038/s41401-021-00833-y

PMCID:
PMC9343462

PMID:
34937917

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was financially supported by National Natural Science Foundation of China (Grant No.81770667), Scientific Research Project of Guangdong Provincial People’s Hospital-Summit plan (Grant No. KJ012019120, No. KJ012019433) and Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases (Grant No.2019B121205005)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025